Upregulation of inflammatory cytokines (e.g., IL-6 and IL-8) induced by CS treatment may be correlated with pulmonary function, disease severity, and clinical outcomes of COPD patients [20, 21]. Here, IL6 is linked to chronic obstructive pulmonary disease.